ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

50 hedge funds and large institutions have $213M invested in Albireo Pharma, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
50
Holders Change
+20
Holders Change %
+66.67%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
15
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$20.4M
2
ACH
2
ArrowMark Colorado Holdings
Colorado
$13.2M
3
PA
3
Perceptive Advisors
New York
$55.5M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$10.1M
5
AG
5
Artal Group
Luxembourg
$17.8M

Top Sellers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$5.63M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$3.01M
3
SFM
3
Sphera Funds Management
Israel
$0
4
CIBC Private Wealth Group
4
CIBC Private Wealth Group
Georgia
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$282K
Name Market Value Shares Shares
Change 		Shares
Change %
CIBC Private Wealth Group
51
CIBC Private Wealth Group
Georgia
– – -2,000 Closed
Macquarie Group
52
Macquarie Group
Australia
– – -300 Closed
TRCT
53
Tower Research Capital (TRC)
New York
– – -65 Closed
LTFS
54
Ladenburg Thalmann Financial Services
Florida
– – -33 Closed
Group One Trading
55
Group One Trading
Illinois
$0 2 – –
1 2
3